Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertugliflozin + metformin in Asian adults with type 2 diabetes inadequately controlled on metformin
CTR20150701Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ertugliflozin in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Feb 2016; status: completed.
02
Drugs
ertugliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20150701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150701.